L
Laura Rivino
Researcher at University of Bristol
Publications - 46
Citations - 3547
Laura Rivino is an academic researcher from University of Bristol. The author has contributed to research in topics: Dengue virus & Dengue fever. The author has an hindex of 22, co-authored 37 publications receiving 3053 citations. Previous affiliations of Laura Rivino include Charité & National University of Singapore.
Papers
More filters
Journal ArticleDOI
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Eva V. Acosta-Rodríguez,Laura Rivino,Jens Geginat,David Jarrossay,Marco Gattorno,Antonio Lanzavecchia,Federica Sallusto,Giorgio Napolitani +7 more
TL;DR: It is demonstrated that human TH-17 cells have distinct migratory capacity and antigenic specificities and a link between microbial products, T helper cell differentiation and homing in response to fungal antigens is established.
Journal ArticleDOI
Chemokine Receptor Expression Identifies Pre–T Helper (Th)1, Pre–Th2, and Nonpolarized Cells among Human CD4+ Central Memory T Cells
TL;DR: It is shown that three chemokine receptors identify functional subsets within the human CD4+ TCM cell pool, which explain how the quality of primary T cell responses could be maintained by TCM cells in the absence of antigen.
Journal ArticleDOI
Differential Targeting of Viral Components by CD4+ versus CD8+ T Lymphocytes in Dengue Virus Infection
Laura Rivino,Emmanuelle A. P. Kumaran,Vojislav Jovanovic,Karen Donceras Nadua,En Wei Teo,Shyue Wei Pang,Guo Hui Teo,Victor C. Gan,David C. Lye,David C. Lye,Yee Sin Leo,Yee Sin Leo,Brendon J. Hanson,Kenneth G. C. Smith,Antonio Bertoletti,Antonio Bertoletti,David M. Kemeny,Paul A. MacAry +17 more
TL;DR: During a dengue virus infection, the protein targets of human CD4+ and CD8+ T cells are largely distinct, thus highlighting key differences in the immunodominance of DENV proteins for these two cell types has important implications for understanding how the two arms of the human adaptive immune system are differentially targeted and employed as part of the response to DENV infection.
Journal ArticleDOI
Hepatitis B virus–specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation
Laura Rivino,Nina Le Bert,Nina Le Bert,Upkar S. Gill,Upkar S. Gill,Kamini Kunasegaran,Yang Cheng,D. Tan,Etienne Becht,N. Hansi,Graham R. Foster,Tung-Hung Su,Tai-Chung Tseng,Seng Gee Lim,Jia-Horng Kao,Evan W. Newell,Patrick T F Kennedy,Antonio Bertoletti,Antonio Bertoletti,Antonio Bertoletti +19 more
TL;DR: This study identifies the presence of functional HBV-specific T cells as a candidate immunological biomarker for safe therapy discontinuation in chronic HBV patients and highlights the potential beneficial role of the expression of T cell exhaustion markers during human chronic viral infection.
Journal ArticleDOI
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection
Nina Le Bert,Upkar S. Gill,Michelle Hong,Kamini Kunasegaran,D. Tan,Raidah Ahmad,Yang Cheng,Charles-A. Dutertre,Charles-A. Dutertre,Andreas Heinecke,Laura Rivino,Laura Rivino,Anthony T. Tan,N. Hansi,Min Zhang,Sujuan Xi,Yutian Chong,Stefan Pflanz,Evan W. Newell,Patrick T F Kennedy,Antonio Bertoletti,Antonio Bertoletti +21 more
TL;DR: Although the presence of HBs-specific T cells might not be required for clearance of HBV infection in all patients, strategies to restore anti-HBV immune responses should consider patients younger than 30 years.